Mainz Biomed (MYNZ) supports Colorectal Cancer Awareness Month in March. Detecting colorectal cancer in its early stages significantly improves ...
Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention ...
16h
Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in ...
Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the ...
Partnership to Launch DNA-Based Colorectal Cancer Screening TestBERKELEY, Calif. and MAINZ, Germany, Feb. 20, 2025 (GLOBE ...
Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the early ...
MYNZ stock opened at $6.04 on Friday. Mainz Biomed has a one year low of $3.65 and a one year high of $45.60. The company’s fifty day moving average price is $5.32 and its 200-day moving average ...
Analyst Price Forecast Suggests 66.00% Downside As of November 21, 2024, the average one-year price target for Mainz Biomed N.V. is $2.04/share. The forecasts range from a low of $2.02 to a high ...
1 Day MYNZ -7.50% DJIA -0.37% Russell 2K -0.10% Health Care/Life Sciences 0.69% ...
Independent hotel brand launches new travel booking and management platform for advisors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback